BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) shares were down 1.3% during trading on Wednesday . The company traded as low as $0.74 and last traded at $0.77. Approximately 40,241 shares traded hands during mid-day trading, a decline of 26% from the average daily volume of 54,108 shares. The stock had previously closed at $0.78.
Analyst Upgrades and Downgrades
Separately, HC Wainwright restated a “buy” rating and issued a $2.00 price target on shares of BiomX in a report on Wednesday, January 8th.
Read Our Latest Report on BiomX
BiomX Stock Performance
About BiomX
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
See Also
- Five stocks we like better than BiomX
- What is the NASDAQ Stock Exchange?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Steel Stocks Soaring After Tariff Announcements
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
